Latest News

The announcement comes as part of Dubai’s Economic Agenda D33, which aims to position the emirate as a global healthcare destination.

The conference has attracted significant participation, with 405 scientific abstracts submitted and 22 symposiums scheduled throughout the week.

Dr. Musuva takes the helm following the departure of Dr. Tim Theuri, whose fixed-term contract as CEO concluded on February 8th, 2026.

The healthcare zone centers around Thumbay University Hospital Dubai, which launches in Phase One with specialized services including renal dialysis, cardiology, orthopedics, and rehabilitation.

Dubai serves as a progressive model that brings healthcare stakeholders together under a unified vision focused on prevention, preparedness, and quality of life.

The Cardiovascular CoE brings together cardiology, cardiac surgery, and vascular medicine within a single coordinated program.

The acquisition gives Lilly access to Orna’s innovative platform, which combines circular RNA (circRNA) with lipid nanoparticle-based therapies.

The validation follows a Joint External Evaluation conducted in September 2024, which assessed the country’s capacity to prevent, detect, and respond to public health threats.

The expansion also aligns with the government’s National Cancer Plan for England, which focuses on accelerating patient diagnosis and improving access to treatment nationwide.

The new San Diego facility will function as a critical node in Novartis’s integrated global research network, connecting seamlessly with existing research hubs in Basel, Switzerland, and Cambridge, Massachusetts.